Reviva Pharmaceuticals Holdings, Inc. RVPH:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
1.64quote price arrow down-0.03 (-1.80%)
Volume
1,694,693
Close
1.67quote price arrow down-0.04 (-2.34%)
Volume
306,917
52 week range
1.60 - 8.30
Loading...
  • Open1.71
  • Day High1.72
  • Day Low1.62
  • Prev Close1.71
  • 52 Week High8.30
  • 52 Week High Date05/18/23
  • 52 Week Low1.60
  • 52 Week Low Date05/15/24

Key Stats

  • Market Cap46.624M
  • Shares Out27.92M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.08
  • YTD % Change-67.57

KEY STATS

  • Open1.71
  • Day High1.72
  • Day Low1.62
  • Prev Close1.71
  • 52 Week High8.30
  • 52 Week High Date05/18/23
  • 52 Week Low1.60
  • 52 Week Low Date05/15/24
  • Market Cap46.624M
  • Shares Out27.92M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.08
  • YTD % Change-67.57

RATIOS/PROFITABILITY

  • EPS (TTM)-1.66
  • P/E (TTM)-1.01
  • Fwd P/E (NTM)-1.19
  • EBITDA (TTM)-39.504M
  • ROE (TTM)-556.38%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Reviva Pharmaceuticals Holdings, Inc.

 

Profile

MORE
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops, and seeks to commercialize therapeutics for diseases representing unmet medical needs. The Company’s pipeline focuses on the central nervous system, respiratory and metabolic diseases. Its pipeline includes two drug candidates, RP5063 (brilaroxazine) and RP1208. Its lead drug candidate, brilaroxazine, is in clinical development and is to treat multiple...
Parag Saxena
Independent Chairman of the Board
Laxminarayan Bhat Ph.D.
President, Chief Executive Officer, Director
Narayan Prabhu
Chief Financial Officer
Address
10080 N Wolfe Road, Suite Sw3-200
Cupertino, CA
95014
United States

Top Peers

SYMBOLLASTCHG%CHG
CKPT
Checkpoint Therapeutics Inc
1.88+0.10+5.62%
INTS
Intensity Therapeutics Inc
4.89-0.21-4.12%
AVRO
AVROBIO Inc
1.39UNCHUNCH
QTTB
Q32 Bio Inc
30.36-0.64-2.06%
IMMX
Immix Biopharma Inc
2.47+0.22+9.78%